首页> 外文期刊>Acta Poloniae Pharmaceutica: Durg Research >Induction of the expression of genes encoding tgf-β isoforms and their receptors by inositol hexaphosphate in human colon cancer cells
【24h】

Induction of the expression of genes encoding tgf-β isoforms and their receptors by inositol hexaphosphate in human colon cancer cells

机译:六磷酸肌醇在人结肠癌细胞中诱导编码tgf-β同工型及其受体的基因表达

获取原文
获取原文并翻译 | 示例
       

摘要

Transforming growth factors-β (TGF-β) are multifunctional cytokines involved in the regulation of cell development, differentiation, survival and apoptosis. They are also potent anticancer agents that inhibit uncontrolled proliferation of cells. Incorrect TGF-β regulation has been implicated in the pathogenesis of many diseases including inflammation and cancer. In humans, the TGF-β family consists of three members (TGF-β1, 2, 3) that show high similarity and homology. TGF-βs exert biological activities on various cell types including neoplastic cells via their specific receptors. Inositol hexaphosphate (phytic acid, IP6), a phytochemical has been reported to possess various health benefits. The aim of this study was to examine the effect of IP6 on the expression of genes encoding TGF-β1, TGF-β2, TGF-β3 isoforms and their receptors TβRI, TβRII, TβRIII in human colorectal cancer cell line Caco-2. The cells were treated with 0.5, 1 and 2.5 mM IP6 for 3, 6 and 12 h. The untreated Caco-2 cells were used as the control. Quantification of genes expression was performed by real time QRT-PCR technique with a SYBR Green I chemistry. The experimental data revealed that the TGF-β1 mRNA was the predominant isoform in Caco-2 cells and that IP6 enhanced transcriptional activity of genes of all three TGF-β isoforms and their receptors TβRI, TβRII TβRIII in these cells. At concentrations up to 1 mM, IP6 over-expressed the genes in 6 h lasting cultures, and its higher dose (2.5 mM) caused successively increasing transcript level of TGF-β isoforms and receptors with the duration of experiment up to 12 h. The findings of this study indicate that one of anti-cancer abilities of IP6 can be realized by enhancing the gene expression of TGF-β isoforms and their receptors at the transcriptional level.
机译:转化生长因子-β(TGF-β)是参与细胞发育,分化,存活和凋亡调控的多功能细胞因子。它们还是抑制细胞不受控制的增殖的有效抗癌剂。 TGF-β调节不正确与多种疾病的发病机制有关,包括炎症和癌症。在人类中,TGF-β家族由三个成员(TGF-β1、2、3)组成,它们具有很高的相似性和同源性。 TGF-β通过其特异性受体对包括肿瘤细胞在内的多种细胞类型发挥生物活性。据报道,六磷酸肌醇(植酸,IP6)具有多种健康益处。这项研究的目的是检验IP6对人结肠直肠癌细胞系Caco-2中编码TGF-β1,TGF-β2,TGF-β3亚型及其受体TβRI,TβRII,TβRIII的基因表达的影响。用0.5、1和2.5mM IP6处理细胞3、6和12小时。未处理的Caco-2细胞用作对照。基因表达的定量是通过实时QRT-PCR技术和SYBR Green I化学方法进行的。实验数据表明,TGF-β1mRNA是Caco-2细胞中主要的亚型,IP6增强了这三种TGF-β异构体的基因及其受体TβRI,TβRII,TβRIII的转录活性。在浓度高达1 mM的情况下,IP6在持续培养6 h的过程中过表达该基因,其较高剂量(2.5 mM)导致TGF-β同工型和受体的转录水平在实验过程中持续增加,直至12 h。这项研究的发现表明IP6的一种抗癌能力可以通过在转录水平上增强TGF-β亚型及其受体的基因表达来实现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号